Cargando…

Lobular breast cancer: molecular basis, mouse and cellular models

Infiltrating lobular breast cancer (ILC) is the most common special breast cancer subtype. With mutational or epigenetic inactivation of the cell adhesion molecule E-cadherin (CDH1) being confined almost exclusively to ILC, this tumor entity stands out from all other types of breast cancers. The mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christgen, Matthias, Derksen, Patrick WB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320436/ https://www.ncbi.nlm.nih.gov/pubmed/25757734 http://dx.doi.org/10.1186/s13058-015-0517-z

Ejemplares similares

Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions
por: Sflomos, George, et al.
Publicado: (2021)

Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors
por: Christgen, Matthias, et al.
Publicado: (2021)

E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
por: Christgen, Matthias, et al.
Publicado: (2020)

Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma
por: Sflomos, George, et al.
Publicado: (2023)

High frequency of lobular breast cancer in distant metastases to the orbit
por: Raap, Mieke, et al.
Publicado: (2015)

Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma
por: Christgen, Matthias, et al.
Publicado: (2021)

Methylation biomarkers for pleomorphic lobular breast cancer - a short report
por: Moelans, Cathy B., et al.
Publicado: (2015)

Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells
por: van Agthoven, Ton, et al.
Publicado: (2015)

αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer
por: de Groot, Jolien S, et al.
Publicado: (2018)

Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer
por: Vlug, Eva J., et al.
Publicado: (2013)

Lobular breast cancer series: imaging
por: Johnson, Karen, et al.
Publicado: (2015)

ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer
por: Grote, Isabel, et al.
Publicado: (2022)

Molecular Classification of Lobular Carcinoma of the Breast
por: Fu, Denggang, et al.
Publicado: (2017)

Deciphering the molecular landscape of metastatic lobular breast cancer
por: Dandachi, Nadia, et al.
Publicado: (2022)

Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11 expression
por: van de Ven, Robert A. H., et al.
Publicado: (2015)

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast
por: Ercan, Cigdem, et al.
Publicado: (2012)

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
por: De Schepper, Maxim, et al.
Publicado: (2022)

Lobular breast cancer: incidence and genetic and non-genetic risk factors
por: Dossus, Laure, et al.
Publicado: (2015)

Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid‐papillary carcinoma
por: Christgen, Matthias, et al.
Publicado: (2017)

Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods
por: Oliveira, Tatiane M. G., et al.
Publicado: (2014)

Molecular drivers of lobular carcinoma in situ
por: Logan, Greg J., et al.
Publicado: (2015)

Prophylaxis of hereditary breast cancer
por: de Groot, Jolien S., et al.
Publicado: (2017)

Improved mouse model of invasive lobular carcinoma
Publicado: (2011)

Genomic assays for lobular breast carcinoma
por: Göker, Menekse, et al.
Publicado: (2022)

Cellular and molecular basis of Venous insufficiency
por: Pocock, Elizabeth S, et al.
Publicado: (2014)

Cellular and molecular basis of thyroid autoimmunity
por: Bogusławska, Joanna, et al.
Publicado: (2021)

The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003)

Lobular Breast Cancer: A Review
por: Wilson, Natalie, et al.
Publicado: (2021)

The Genomic Landscape of Lobular Breast Cancer
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Clinical validity and clinical utility of Ki67 in early breast cancer
por: Kreipe, Hans, et al.
Publicado: (2022)

Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer
por: Mastracci, Teresa L, et al.
Publicado: (2007)

The cellular and molecular basis of cnidarian neurogenesis
por: Rentzsch, Fabian, et al.
Publicado: (2016)

Cellular and molecular basis for endometriosis-associated infertility
por: Stilley, Julie A. W., et al.
Publicado: (2012)

Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast Cancer
por: Alexander, John, et al.
Publicado: (2022)

Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
por: Reed, Amy E McCart, et al.
Publicado: (2015)

E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer
por: Teo, Katy, et al.
Publicado: (2018)

Elucidating metastasis mechanisms in lobular breast cancer
Publicado: (2015)

Immune Infiltration in Invasive Lobular Breast Cancer
por: Desmedt, Christine, et al.
Publicado: (2018)

Characterisation of the Stromal Microenvironment in Lobular Breast Cancer
por: Gómez-Cuadrado, Laura, et al.
Publicado: (2022)

Invasive lobular carcinoma of the breast.
por: Hayes, D., et al.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_q4e2fnahn0nm59l37rfdk8gnco